Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer

By Garcia Agustin A.   Yessaian Anne   Pham Huyen   Facio Grace   Muderspach Laila   Roman Lynda  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 295-299

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study

By Mitachi Yashushi   Sakata Yuh   Ohtsu Atsushi   Hyodo Ichinosuke   Katsu Kenichi   Sairenji Motonori   Saitoh Soh   Suwa Toshikazu   Sato Toshinobu   Miyata Yoshinori  

Gastric Cancer, Vol. 5, Iss. 3, 2002-09 ,pp. : 160-167

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of docetaxel in chemotherapy-naive patients with recurrent or metastatic adult soft tissue sarcoma

By Bramwell Vivien   Blackstein Martin   Belanger Karl   Verma Shail   Beare Sandra   Eisenhauer Elizabeth  

Sarcoma, Vol. 2, Iss. 1, 1998-03 ,pp. : 29-33

Informa Healthcare

Access to resources Recommend Favorite

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

By Diéras Véronique   Guastalla Jean   Ferrero Jean   Curé Hervé   Weber Béatrice   Winckel Philippe   Lortholary Alain   Mayer Françoise   Paraiso Désiré   Magherini Emmanuelle   Pujade-Lauraine Eric  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 489-495

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of docetaxel, cisplatin and S1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 898-904

Spandidos Publications

Access to resources Recommend Favorite